Noticias de XTLB_US

Noticias del mercado

Últimas noticias sobre XTLB_US — 93 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: XTLB_US ✕ 93 resultados
16/05/2026 XTLB_US — The Globe and Mail
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
15/05/2026 XTLB_US — TipRanks
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
15/05/2026 XTLB_US — Investing.com ES ← EN
XTL Biopharmaceuticals programa junta extraordinaria de accionistas para el 22 de junio

XTL Biopharmaceuticals schedules extraordinary shareholder meeting for June 22

15/05/2026 XTLB_US — Intellectia AI
XTLB Technical Analysis & Stock Price Forecast

Obtenga análisis técnicos XTLB, promedios móviles, indicadores RSI y MACD en tiempo real. Vea pronósticos de acciones profesionales y señales de compra/venta.

15/05/2026 XTLB_US — Stock Titan
Psyga acquisition and US$1.5M private placement up for XTLB shareholder vote
15/05/2026 XTLB_US — Investing.com
XTL Biopharmaceuticals schedules extraordinary shareholder meeting for June 22
12/05/2026 XTLB_US — TradingKey ES ← EN
Clave comercial

TradingKey

07/05/2026 XTLB_US — Investing.com South Africa
Nasdaq grants XTL Biopharmaceuticals conditional extension for continued listing By Investing.com
07/05/2026 XTLB_US — Investing.com Nigeria
Nasdaq grants XTL Biopharmaceuticals conditional extension for continued listing By Investing.com
07/05/2026 XTLB_US — Investing.com ES ← EN
Nasdaq otorga a XTL Biopharmaceuticals una extensión condicional para continuar cotizando

Nasdaq grants XTL Biopharmaceuticals conditional extension for continued listing

07/05/2026 XTLB_US — Investing.com
Nasdaq grants XTL Biopharmaceuticals conditional extension for continued listing
07/05/2026 XTLB_US — Stock Titan
Conditional Nasdaq lifeline for XTL Biopharmaceuticals (NASDAQ: XTLB) tied to Psyga deal
07/05/2026 XTLB_US — TipRanks
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
04/05/2026 XTLB_US — Mugglehead Investment Magazine
XTL Biopharma to enter psychedelics sector with Psyga Bio takeover
30/04/2026 XTLB_US — TipRanks
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
29/04/2026 XTLB_US — Newser ES ← EN
XTLB (XTL) destaca el progreso prometedor de la cartera biofarmacéutica junto con sus últimos resultados de ganancias trimestrales. - Alertas de riesgo de multitudes

XTLB (XTL) highlights promising biopharma pipeline progress alongside its latest quarterly earnings results. - Crowd Risk Alerts

29/04/2026 XTLB_US — Investing.com South Africa ES ← EN
XTL Biopharmaceuticals adquirirá Psyga Bio por una participación del 40% Por Investing.com

XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake By Investing.com

29/04/2026 XTLB_US — newsline.com
XTLB (XTL) highlights promising biopharma pipeline progress alongside its latest quarterly earnings results.
29/04/2026 XTLB_US — newser.com
XTLB (XTL) highlights promising biopharma pipeline progress alongside its latest quarterly earnings results. - Social Buzz Stocks
29/04/2026 XTLB_US — Newser
XTLB (XTL) highlights promising biopharma pipeline progress alongside its latest quarterly earnings results. - Trader Community Signals

Página 2 de 5

keyboard_arrow_up